Cerence Inc. CRNC
7.95
0.02
0.25%
as of 25 Sep
- Market cap
- $358.7M
- P/E
- 0.0×
Follow CRNC
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 1,069.00 | 0.00 | 0.00 |
P/S ratio |
2.14 | 1.52 | 0.94 | 1.65 | |
P/FCF ratio |
11.49 | 6.44 | 3.79 | 6.50 | |
P/Operating CF |
42.19 | 12.68 | 20.17 | 25.63 | |
P/B ratio |
3.57 | 3.19 | 1.79 | 3.07 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
2.82 | 1.96 | 1.35 | 1.99 | |
EV/EBITDA |
86.02 | 11.39 | 12.07 | 16.76 | |
EV/Operating CF |
11.61 | 6.88 | 4.62 | 7.29 | |
EV/FCF |
15.17 | 8.29 | 5.45 | 7.85 | |
Quick Ratio |
1.45 | 1.47 | 1.60 | 1.70 | |
Current Ratio |
1.89 | 1.88 | 1.90 | 2.08 | |
Net Debt/EBITDA |
408.16 | 2.45 | 185.67 | 9.71 | |
Debt/Assets |
31.67% | 28.56% | 27.99% | 27.93% | |
Debt/Equity |
1.33 | 1.14 | 1.09 | 1.04 | |
Asset Turnover |
0.38 | 0.52 | 0.47 | 0.49 | |
Operating CF/Net income |
(0.95) | (7.23) | 8.43 | 13.02 | |
Capex/Depreciation |
(1.47) | (1.03) | (0.17) | (0.12) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
43.54% | 21.46% | 47.20% | 42.02% | |
Selling, General and Administrative Expense of Revenue |
30.81% | 32.63% | 30.09% | 29.52% | |
Intangible Assets out of Total Assets |
0.47 | 0.50 | 0.48 | 0.48 | |
Share Based Compensation of Revenue |
12.05% | 4.64% | 10.52% | 10.80% | |
Graham Net Nets |
(0.54) | (0.55) | (0.89) | (0.47) | |
Graham Number |
0.00 | 0.87 | 0.00 | 0.00 | |
Earnings Yield |
(3.53%) | 0.09% | (7.13%) | (3.18%) | |
Free Cash Flow Yield |
8.70% | 15.52% | 26.38% | 15.37% | |
Revenue per Share |
1.40 | 2.56 | 1.42 | 1.54 | |
Operating CF per Share |
0.30 | 0.84 | 0.31 | 0.44 | |
Capex per Share |
(0.07) | (0.05) | (0.01) | (0.01) | |
Free Cash Flow per Share |
0.23 | 0.79 | 0.30 | 0.43 | |
Cash per Share |
2.03 | 2.11 | 2.40 | 2.82 | |
Shareholders Equity per Share |
3.49 | 3.35 | 3.52 | 3.68 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.49 | 3.35 | 3.52 | 3.68 | |
Free Cash Flow |
9.75 | 35.65 | 13.63 | 19.62 | |
Working Capital |
89.57 | 86.90 | 96.98 | 110.32 | |
Capital Expenditures |
(3.00) | (2.25) | (0.48) | (0.34) | |
Net Current Asset Value |
(289.16) | (265.46) | (254.10) | (242.33) | |
EV/EBIT |
0.00 | 14.06 | 16.93 | 22.88 | |
Capex to Sales |
0.05 | 0.02 | 0.01 | 0.00 | |
Net Profit Margin |
(22.03%) | (4.55%) | 2.61% | 2.20% | |
Price to Operating Income |
0.00 | 10.93 | 11.78 | 18.96 | |
| Other line items | |||||
Average Receivables |
60.85 | 49.45 | 64.31 | 54.06 | |
Average Payables |
2.43 | 6.23 | 7.08 | 4.12 | |
Average Assets |
666.47 | 609.79 | 641.25 | 628.87 | |
Average Common Equity |
145.89 | 135.57 | 153.91 | 161.01 |
Columns are period end dates